O

Oxford Biomedica

672 employees

Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Viral vector GMP manufacturing
Immunotherapy
Therapeutics
Cell and gene therapy
Genetics
Gene therapy

Date founded

1995

Funding rounds raised

Total raised

$4.2M

from 2 investors over 2 rounds

O

Oxford Biomedica raised undisclosed on May 1, 2019

Investors: Novo Holdings

O

Oxford Biomedica raised $4.2M on January 23, 2018

Investors: Innovate UK

FAQ